PNLIP and obesity due to melanocortin 4 receptor deficiency: It has been clinically reported that a pancreatic lipase inhibitor such as orlistat prevented obesity and hyperlipidemia through the increment of fat excretion into feces and the inhibition of pancreatic lipase [34].